Alexa Overseas

VaxiFlu 4 Vaccine is given as an injection into a muscle by a doctor or nurse. It is usually given just before the cold season when the flu virus begins to increase. Normally, only one injection is required to protect you for a year. You should have the vaccination each year because different new strains of the flu virus emerge frequently and different vaccines are developed. It is especially important to have this vaccine if you are elderly or have chronic health problems such as diabetes, heart failure, kidney failure, or chronic obstructive pulmonary disease (COPD). It is also recommended for young children over 6 months of age.

This vaccine can cause mild side effects, but it is better to get vaccinated than to become infected with flu. The most common side effects include headache, muscle pain, weakness, tiredness, bruising, joint pain, sweating, shivering, and pain or swelling at the vaccination site. They do not normally last very long. Consult your doctor if any of the side effects persist or worry you.

Before having the injection, you should tell your doctor if you have an illness with a high temperature or if you have ever had an allergic reaction to a vaccine. Some other medicines may react with the flu vaccine so talk to your doctor about other medications you are taking as well. As with any vaccine, vaccination may not fully protect everybody, although it will reduce the symptoms of the flu if you get it. It will not prevent illness from avian flu (bird flu) or a common cold. Consult your doctor first if you are pregnant or breastfeeding.

Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection. Immunity has been demonstrated one month after vaccination and has been shown to persist up to the next re-vaccination dose.

Raboral V-RG® is an oral rabies recombinant vaccine that protects raccoons and coyotes against rabies, thereby reducing the risk of exposure to rabies to humans and domestic animals. It is only sold to government agencies conducting rabies control programs.

Hevrevac® is indicated for the active immunization against infection caused by Hepatitis E virus (HEV) in adults aged 18 to 65 years.

Hevrevac® is indicated for the active immunization against infection caused by Hepatitis E virus (HEV) in adults aged 18 to 65 years.

Each 0.5 mL dose contains 30 µg of purified recombinant HEV239 protein, expressed in E. coli, adjuvanted with aluminum hydroxide.